| NCT06740474 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants | RECRUITING | PHASE1 | 2025-01-31 | 2025-08 | 2025-08 |
| NCT06698575 | A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes | RECRUITING | PHASE1 | 2024-12-08 | 2025-12 | 2025-11 |
| NCT06384131 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection | COMPLETED | PHASE1 | 2024-06-04 | 2025-05-14 | 2025-04-15 |
| NCT06385327 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes | RECRUITING | PHASE1 | 2024-05-30 | 2025-12 | 2025-12 |
| NCT05569941 | A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects | COMPLETED | PHASE1 | 2022-11-11 | 2023-04-12 | 2023-04-12 |
| NCT05414981 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection | COMPLETED | PHASE1 | 2022-08-07 | 2023-04-24 | 2023-04-24 |
| NCT04820686 | A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection | TERMINATED | PHASE2 | 2021-05-07 | 2023-03-30 | 2023-03-30 |
| NCT04781647 | A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection | TERMINATED | PHASE2 | 2021-02-18 | 2022-12-02 | 2022-12-02 |
| NCT04637139 | A Study to Evaluate the Mass Balance Absorption and AME of VBR | COMPLETED | PHASE1 | 2020-12-01 | 2020-12-22 | 2020-12-22 |
| NCT04454567 | A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors | TERMINATED | PHASE2 | 2020-11-11 | 2021-04-08 | 2021-04-08 |
| NCT04398134 | A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection | TERMINATED | PHASE2 | 2020-08-28 | 2021-12-28 | 2021-10-14 |
| NCT04271592 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults | COMPLETED | PHASE1 | 2020-05-17 | 2021-01-14 | 2020-11-03 |
| NCT04142762 | A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults | COMPLETED | PHASE1 | 2019-10-18 | 2020-01-29 | 2020-01-12 |
| NCT04083716 | A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults | COMPLETED | PHASE1 | 2019-09-06 | 2019-10-07 | 2019-10-05 |
| NCT03923478 | ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis | TERMINATED | PHASE1 | 2019-06-24 | 2021-01-20 | 2021-01-20 |
| NCT03780543 | A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients | TERMINATED | PHASE2 | 2018-12-20 | 2021-04-26 | 2021-04-26 |
| NCT03714152 | A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B | COMPLETED | PHASE1 | 2018-11-13 | 2021-01-07 | 2020-11-23 |
| NCT03577171 | A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) | COMPLETED | PHASE2 | 2018-06-19 | 2019-06-21 | 2019-06-21 |
| NCT03576066 | A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection | COMPLETED | PHASE2 | 2018-06-11 | 2019-07-05 | 2019-07-05 |
| NCT03109730 | Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B | COMPLETED | PHASE1, PHASE2 | 2017-06-15 | 2018-06-12 | 2018-03-31 |
| NCT02908191 | A Study in Healthy Volunteers and Patients With Chronic Hepatitis B | COMPLETED | PHASE1 | 2016-11 | 2018-06-12 | 2018-03-31 |